← All peptides
Healing & Recovery
Research Chemical

Dermorphin

Also known as: Dermorphin

Dermorphin is a naturally occurring opioid heptapeptide originally isolated from the skin of South American Phyllomedusa frogs that acts as an extremely potent and selective mu-opioid receptor agonist.

Last updated

Mechanism of Action

Dermorphin is a D-amino-acid-containing heptapeptide (Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2) that binds with very high affinity and selectivity to the mu-opioid receptor (MOR), a Gi/Go-coupled GPCR. Activation inhibits adenylyl cyclase, reduces cAMP, opens inwardly rectifying potassium channels and closes voltage-gated calcium channels, producing potent analgesia. The unnatural D-alanine residue confers resistance to peptidase degradation, giving it analgesic potency reported to be many times greater than morphine on a molar basis.

Half-life
Relatively short; on the order of minutes to a couple of hours depending on route
Administration Routes
subcutaneous
Research Status
Research Chemical

Reported Benefits

  • Extremely potent analgesic activity in animal models
  • High selectivity for the mu-opioid receptor
  • Peptidase resistance from D-amino-acid content
  • Used as a research probe for opioid receptor pharmacology

Potential Side Effects

  • Respiratory depression
  • Sedation and drowsiness
  • Physical dependence and tolerance with repeated use
  • Constipation and gastrointestinal slowing
  • Risk of overdose given high potency

Common Dosing

No legitimate human dosing exists; it is encountered in research and as a doping agent in animals. For laboratory research use only and never intended for human administration.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Not for human use under any circumstance
  • Avoid with other opioids or CNS depressants
  • Respiratory insufficiency
  • History of substance use disorder

No documented stacking partners for Dermorphin yet.

  • Amino acid composition and sequence of dermorphin, a novel opiate-like peptide from the skin of Phyllomedusa sauvagei

    1981

    View
  • Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin

    1981

    View
  • Rediscovery of old drugs: the forgotten case of dermorphin for postoperative pain and palliation

    2018

    View
  • Pharmacokinetics and pharmacodynamics of dermorphin in the horse

    2015

    View

It was originally isolated from the skin secretions of South American tree frogs of the genus Phyllomedusa.

It is an extremely potent mu-opioid agonist many times stronger than morphine, carrying high risks of respiratory depression, dependence, and overdose. It has no approved human use.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.